These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Congenital parvovirus B19 infection: experience of a recent epidemic. Kailasam C; Brennand J; Cameron AD Fetal Diagn Ther; 2001; 16(1):18-22. PubMed ID: 11125246 [TBL] [Abstract][Full Text] [Related]
24. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Nagel HT; de Haan TR; Vandenbussche FP; Oepkes D; Walther FJ Obstet Gynecol; 2007 Jan; 109(1):42-7. PubMed ID: 17197586 [TBL] [Abstract][Full Text] [Related]
25. Resolution of human parvovirus B19-induced nonimmune hydrops after intrauterine transfusion. Odibo AO; Campbell WA; Feldman D; Ling PY; Leo MV; Borgida AF; Rodis JF J Ultrasound Med; 1998 Sep; 17(9):547-50. PubMed ID: 9733171 [TBL] [Abstract][Full Text] [Related]
26. Non-isotopic in situ hybridisation and immunophenotyping of infected cells in the investigation of human fetal parvovirus infection. Morey AL; Porter HJ; Keeling JW; Fleming KA J Clin Pathol; 1992 Aug; 45(8):673-8. PubMed ID: 1401175 [TBL] [Abstract][Full Text] [Related]
27. Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis. Nunoue T; Kusuhara K; Hara T Pediatr Infect Dis J; 2002 Dec; 21(12):1133-6. PubMed ID: 12488663 [TBL] [Abstract][Full Text] [Related]
28. Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Koch WC; Harger JH; Barnstein B; Adler SP Pediatr Infect Dis J; 1998 Jun; 17(6):489-94. PubMed ID: 9655540 [TBL] [Abstract][Full Text] [Related]
29. Hydrops fetalis caused by parvovirus B19 infection: case report and literature review. Taksaphan S; Kleebkaew P; Komwilaisak R; Kiatchoosakun P; Jirapradittha J; Ratanasiri T J Med Assoc Thai; 2006 Aug; 89(8):1277-86. PubMed ID: 17048441 [TBL] [Abstract][Full Text] [Related]
30. Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit. Simms RA; Liebling RE; Patel RR; Denbow ML; Abdel-Fattah SA; Soothill PW; Overton TG Fetal Diagn Ther; 2009; 25(4):373-8. PubMed ID: 19786782 [TBL] [Abstract][Full Text] [Related]
31. Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops. Zerbini M; Musiani M; Gentilomi G; Venturoli S; Gallinella G; Morandi R J Clin Microbiol; 1996 Mar; 34(3):603-8. PubMed ID: 8904423 [TBL] [Abstract][Full Text] [Related]
32. Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians. Rodis JF; Borgida AF; Wilson M; Egan JF; Leo MV; Odibo AO; Campbell WA Am J Obstet Gynecol; 1998 Oct; 179(4):985-8. PubMed ID: 9790385 [TBL] [Abstract][Full Text] [Related]
33. Identification of human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis. Jordan JA Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):37-42. PubMed ID: 8572031 [TBL] [Abstract][Full Text] [Related]
34. Detection of parvovirus B19 in fetal autopsies. Schwarz TF; Nerlich A; Hillemanns P Arch Gynecol Obstet; 1993; 253(4):207-13. PubMed ID: 8161255 [TBL] [Abstract][Full Text] [Related]
35. Parvovirus b19 infection in fetal deaths. Riipinen A; Väisänen E; Nuutila M; Sallmen M; Karikoski R; Lindbohm ML; Hedman K; Taskinen H; Söderlund-Venermo M Clin Infect Dis; 2008 Dec; 47(12):1519-25. PubMed ID: 18991512 [TBL] [Abstract][Full Text] [Related]
36. Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Sahakian V; Weiner CP; Naides SJ; Williamson RA; Scharosch LL Am J Obstet Gynecol; 1991 Apr; 164(4):1090-1. PubMed ID: 1849704 [TBL] [Abstract][Full Text] [Related]